N/A
Completed N=17
Dorsal Wrist Ganglia; Aspiration Alone vs Aspiration and Injection of Platelet Rich Plasma
Ganglion of Wrist
Source: ClinicalTrials.gov NCT03408808 ↗
Enrolled (actual)
17
Serious AEs
0.0%
Results posted
Jun 2021
Primary outcomePrimary: Number of Participants With a Recurrence of Ganglia — 8; 5 Participants
Summary
Study to examine the efficacy of Platelet Rich Plasma (PRP) to reduce recurrence in dorsal wrist ganglia (DWG). We will compare aspiration alone and aspiration with injection of PRP.
We plan to recruit a maximum of 200 patients. We will assess the efficacy by contacting the patients by email or telephone at 6 weeks and 12 months. They will be asked to complete a questionnaire and a Patient Evaluated Measure score (PEMS). Adverse events will be screened for/ managed by a telephone call +/- review as necessary between 7 and 14 days.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With a Recurrence of Ganglia |
3; 7 | — |
| SECONDARY PEM Score |
35; 40.6 | — |
Eligibility Criteria
Inclusion Criteria
- Solitary dorsal wrist ganglion.
Exclusion Criteria
- Underlying wrist or ipsilateral arm pathology.
- Unable to consent to treatment.
- Unable or unwilling to attend follow up visits.
Data sourced from ClinicalTrials.gov (NCT03408808). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.